A Community Collaboration Between IU Health and St. Vincent
Current Studies & Research
Resource Facilitation-Best Practices Manual for Return to Work/School

Resource Facilitation: Indiana Best Practices Manual for Return-to- Work or Return-to-School     Click on the read more button to get a link to download the full manual.  Once you… Read More

Multicenter Evaluation of Memory Remediation after TBI with Donepezil (MEMRI-TBI-D Study)

Multicenter Evaluation of Memory Remediation after TBI with Donepezil (MEMRI-TBI-D Study) March 10, 2015 Flora Hammond, MD (PI); Funded by National Institute on Disability and Rehabilitation Research (NIDRR).  This study… Read More

Lifestyle Management in Spinal Cord Injury

New RHI Research Study, seeking participants: Lifestyle Management in Spinal Cord Injury: This pilot study is modeled on a successful lifestyle change program conducted at the University of Pittsburgh.  Based… Read More

Brain Injury Association of America ~ The Challenge

Flora M. Hammond, M.D. is featured as one of the TBI Model Systems Researchers in the Fall Edition of the Brain Injury Association of America ‘The Challenge’ Publication. Click on… Read More

Flora M. Hammond, M.D. Joins Medical Issues Panel of BIAA /Mount Sinai TBI Rehabilitation Guidelines Project

FOR IMMEDIATE RELEASE October 24, 2014   CONTACT: Stephanie S. Hale, BAA, Marketing Public Relations and Marketing Off.: 317-329-2093 Cell: 317-626-2910 stephanie.hale@rhin.com         Flora M. Hammond, M.D.… Read More

SEE ALL RESEARCH
BACK
Post-TBI Irritability & Aggression: Building Evidence-Based Approaches to Management April 26th, 2013

       Flora Hammond, MD (PI), James Malec, PhD (Co-PI), Jacob Kean, PhD, Susan Perkins, PhD, Patrick Monahan, PhD, funded by National Institute on Disability and Rehabilitation Research (NIDRR).

 

  • Treatment and Placebo Arm: “Buspirone for the Treatment of Chronic Post-TBI Irritability and Aggression: A 91-Day Single- Site, Flexible-Dose, Parallel Group, Randomized, Placebo-Controlled Trial”
  • Measurement Arm: “Preliminary Development of the Aggression and Irritability Impact Measure”

 

PURPOSE OF PROJECT: To study the effect expressed by persons with TBI through assessment of buspirone effectiveness for post-traumatic irritability and aggression and development of an irritability/aggression impact measure.

 

SUMMARY OF PROJECT: It is anticipated that 74 subjects with 74 corresponding subject observers will be recruited for the treatment study. Subjects will be recruited from community and self-referrals.

 

Contact Person:  Becky Runkel, at becky.runkel@rhin.com , or at (317) 329-2217.